routin
product
inexpens
vaccin
plant
nearli
two
decad
idealist
larg
unrealis
dream
romant
notion
cheap
edibl
vaccin
earli
year
see
fook
gid
et
al
rybicki
realis
inde
may
never
idea
use
edibl
plant
fruit
deliv
vaccin
still
mean
vaccin
could
pharm
need
obviat
transport
cold
chain
oral
deliveri
seen
easier
safer
simpli
mani
practic
potenti
ethic
problem
concept
implement
envis
first
place
qualiti
control
issu
would
larg
preclud
product
vaccin
food
plant
unless
everi
singl
plant
even
everi
dosag
portion
engin
food
assay
vaccin
content
exampl
would
imposs
guarante
would
enough
dose
vaccin
plant
even
still
produc
vaccin
enough
second
physic
administr
vaccin
need
regul
otherwis
much
littl
could
given
frequent
latter
prospect
especi
rais
spectr
immun
toler
chosen
antigen
elicit
would
negat
whole
raison
vaccin
thu
way
field
develop
recognis
even
though
oral
dose
still
desir
featur
product
process
extent
formul
reproduc
way
given
supervis
ensur
reproduc
effect
howev
recent
research
commerci
develop
well
increas
clariti
regulatori
hurdl
exist
brought
least
part
dream
far
closer
realis
mani
plant
model
tri
rel
limit
number
proven
system
relev
product
vaccin
express
system
includ
stabl
transgen
transplastom
plant
plant
cell
line
induc
constitut
express
express
plant
agrobacterium
transient
express
system
regist
product
produc
accord
good
manufactur
practic
gmp
protocol
enter
clinic
trial
present
sever
independ
facil
capabl
manufactur
materi
human
trial
product
present
plan
clinic
trial
candid
vaccin
produc
human
anim
virus
bacteria
parasit
allergen
cancer
therapeut
review
accordingli
summaris
import
histor
develop
field
well
cover
futur
prospect
discuss
aspect
vaccin
antigen
product
relev
plant
biotechnologist
histori
research
area
recent
extens
cover
see
rybicki
tacket
tiwari
et
al
briefli
detail
import
proof
principl
concept
relev
plant
biotechnolog
also
cover
host
express
system
use
background
latest
develop
trend
term
edibl
fruit
tuber
tomato
engin
express
varieti
antigen
includ
rabi
viru
glycoprotein
g
mcgarvey
et
al
respiratori
syncyti
viru
f
glycoprotein
sandhu
et
al
hepat
e
viru
surfac
protein
et
al
yersinia
pesti
antigen
alvarez
et
al
synthet
hbvhiv
antigen
shchelkunov
et
al
norwalk
viru
capsid
antigen
zhang
et
al
hepat
b
viru
surfac
antigen
hbsag
lou
et
al
synthet
polypeptid
contain
epitop
diphtheria
pertussi
tetanu
dpt
exotoxin
et
al
among
other
paz
de
la
rosa
et
al
paz
de
la
rosa
et
al
express
chimaer
protein
transgen
tomato
string
epitop
hpv
protein
demonstr
combin
prophylactictherapeut
human
papillomaviru
hpv
vaccin
could
made
plant
howev
vlp
produc
stimul
antibodi
respons
yield
high
total
solubl
protein
transgen
potato
tuber
use
produc
escherichia
coli
enterotoxin
haq
et
al
norwalk
viru
coat
protein
mason
et
al
rabbit
haemorrhag
diseas
viru
rhdv
castanon
et
al
hbsag
richter
et
al
combin
cholera
colirotaviru
vaccin
yu
langridg
human
papillomaviru
protein
franconi
et
al
biemelt
et
al
warzecha
et
al
newcastl
diseas
viru
envelop
protein
berinstein
et
al
among
mani
other
rhdv
inject
leaf
strongli
immunogen
protect
rabbit
excel
proof
efficaci
possibl
import
proof
concept
vaccin
human
howev
demonstr
via
clinic
trial
immunogen
hbsag
booster
immunis
convent
vaccin
human
volunt
thanavala
et
al
howev
yield
low
mgkg
even
three
dose
g
raw
potato
work
volunt
unusu
anim
model
use
transgen
potato
tuber
investig
companjen
et
al
demonstr
variou
peptid
green
fluoresc
protein
gfp
translat
fuse
effici
taken
gut
carp
incorpor
crude
extract
standard
feed
pellet
model
vaccin
elicit
specif
system
humor
immun
respons
edibl
leafi
crop
alfalfa
spinach
lupin
lettuc
use
antigen
product
well
one
earli
notabl
success
protect
mice
challeng
foot
mouth
diseas
viru
fmdv
immunis
either
via
oral
parenter
rout
leaf
leaf
homogen
transgen
alfalfa
express
structur
protein
fmdv
wigdorovitz
et
al
mice
fed
transgen
alfalfa
express
highli
immunogen
epitop
fmdv
fuse
glucuronidas
gu
report
gene
protect
experiment
challeng
du
santo
et
al
mice
could
protect
lethal
dose
rabi
viru
fed
transgen
spinach
modelska
et
al
hbsag
produc
transgen
lupin
lettuc
elicit
specif
antibodi
mice
human
respect
kapusta
et
al
sunflow
seed
albumin
produc
lupin
test
vaccin
smart
et
al
small
surfac
antigen
hepat
b
viru
produc
transgen
yellow
lupin
calli
tumour
pniewski
et
al
notabl
achiev
sort
express
human
vaccin
howev
probabl
demonstr
measl
viru
haemagglutinin
protein
could
success
express
transgen
lettuc
immunogen
mice
webster
et
al
follow
work
group
demonstr
first
induc
neutralis
antibodi
mice
huang
et
al
second
measl
immunis
could
success
boost
oral
measl
viru
vaccin
webster
et
al
use
edibl
easili
process
seed
also
initi
popular
given
easier
process
dri
seed
green
leaf
tissu
extract
relev
antigen
seed
tend
preserv
protein
well
long
period
even
ambient
condit
glassif
stabilis
condit
eg
see
gid
et
al
hiroi
takaiwa
lamphear
et
al
streatfield
et
al
maiz
corn
seed
especi
popular
high
potenti
yield
materi
millingprocess
technolog
number
viral
bacteri
antigen
antibodi
success
produc
chikwamba
et
al
chikwamba
et
al
exampl
demonstr
e
coli
toxin
subunit
assembl
correctli
function
protect
mice
bacteri
challeng
inde
prodigen
inc
tx
usa
built
busi
portfolio
around
success
express
variou
vaccin
protein
maiz
seed
lamphear
et
al
horn
et
al
streatfield
et
al
abl
show
maiz
seed
contain
transmiss
gastroenter
viru
tgev
subunit
vaccin
effect
booster
vaccin
system
mucos
immun
pig
lamphear
et
al
rice
investig
product
deliveri
vehicl
reason
maiz
probabl
signific
advantag
maiz
plant
limit
potenti
escap
vaccin
gene
one
recent
innov
find
feed
mice
rice
cri
j
cri
j
allergen
protein
japanes
cedar
reduc
ige
prolif
reaction
histamin
respons
hiroi
takaiwa
vaccin
improv
includ
epitop
triall
human
takaiwa
oszvald
et
al
oszvald
et
al
describ
product
synthet
fusion
gene
compris
e
coli
epitop
porcin
epidem
diarrhoea
viru
oral
vaccin
chicken
transgen
rice
seed
contain
infecti
bursal
diseas
viru
ibdv
protein
result
protect
virul
ibdv
challeng
wu
et
al
recent
antigen
protect
roundworm
ascari
suum
produc
fusion
chimaera
cholera
toxin
ct
b
subunit
ctb
elicit
serum
antibodi
respons
oral
administ
mice
combin
ct
result
lower
lung
worm
burden
challeng
control
mice
matsumoto
et
al
seed
system
legum
investig
see
tiwari
et
al
review
howev
cereal
seed
seem
distinctli
favour
probabl
yield
process
advantag
interest
recent
articl
howev
demonstr
pea
pisum
sativum
ctb
chimaer
protein
protect
rabbit
lethal
challeng
mikschofski
et
al
scienc
world
articl
open
get
vaccin
diseas
could
soon
easi
eat
banana
haq
et
al
goldstein
howev
product
vaccin
edibl
plant
especi
seed
plant
fallen
disfavour
recent
perceiv
problem
contamin
food
crop
due
mainli
two
incid
involv
one
compani
trigger
incid
soya
bean
maiz
harvest
two
state
usa
contamin
transgen
volunt
maiz
plant
seed
express
tgev
capsid
protein
compani
fine
forc
clean
seed
us
depart
agricultur
howev
subsequ
similar
incid
volunt
transgen
maiz
contamin
oat
crop
harvest
bale
use
anim
feed
also
found
grow
flower
nearbi
sorghum
field
led
agreement
compani
successor
would
never
appli
notif
permit
introduc
transgen
plant
aphi
incid
ensu
media
public
concern
led
effect
moratorium
vaccin
pharm
edibl
crop
usa
inde
worldwid
trend
togeth
increas
concern
regulatori
complianc
pharm
product
probabl
stimul
increas
use
crop
plant
especi
vaccin
product
paradox
perhap
success
use
engin
potato
demonstr
potato
could
use
booster
vaccin
human
thanavala
et
al
also
possibl
one
last
time
would
carri
contemporari
review
andi
coghlan
new
scientist
comment
newli
publish
studi
miss
move
develop
abandon
quest
vaccin
contain
stapl
food
like
banana
tomato
potato
coghlan
thu
cultiv
tobacco
plant
varieti
formerli
gener
seen
use
proof
principl
model
plant
increasingli
seen
product
vehicl
futur
anoth
contributori
factor
increas
realis
cheap
edibl
vaccin
compos
raw
plant
materi
easili
realis
first
product
probabl
extens
process
mayb
even
therefor
could
produc
host
first
sight
fit
edibl
paradigm
rybicki
use
nicotiana
spp
mainli
n
tabacum
product
varieti
recombin
protein
well
document
see
rybicki
sharma
sharma
tiwari
et
al
review
cover
depth
howev
use
tobacco
led
mani
earli
proof
concept
principl
thu
first
proof
concept
product
protein
plant
publish
exactli
year
ago
hiatt
et
al
hiatt
et
al
describ
success
product
mous
monoclon
antibodi
mab
transgen
tobacco
nicotiana
tabacum
l
first
vaccin
protein
produc
plant
hepat
b
viru
hbv
surfac
antigen
hbsag
year
later
hugh
mason
et
al
charl
w
arntzen
group
demonstr
transgen
tobacco
contain
relev
gene
control
constitut
promot
produc
hbsag
could
moreov
assembl
planta
characterist
particl
first
describ
blood
peopl
constitut
basi
commerci
recombin
vaccin
recombivax
hb
engerix
b
licenc
respect
mason
et
al
research
group
respons
first
proof
recombin
toxin
protein
function
equival
natur
product
oral
vaccin
anim
produc
antibodi
neutralis
nativ
toxin
haq
et
al
made
transgen
tobacco
potato
plant
contain
gene
encod
e
coli
enterotoxin
plant
express
protein
spontan
oligomeris
pentam
bound
natur
ligand
mice
immunis
gavag
produc
circul
gut
mucos
immunoglobulin
could
neutralis
nativ
enterotoxin
standard
cell
protect
assay
anoth
investig
potenti
plant
produc
equival
vaccin
produc
convent
merck
cervarix
glaxosmithklin
yeast
insect
cell
cultur
group
publish
result
transgen
express
tobacco
andor
potato
two
differ
human
papillomavirus
biemelt
et
al
varsani
et
al
warzecha
et
al
review
elsewher
rybicki
howev
yield
quit
poor
case
maximum
mgkg
proof
principl
particl
resembl
establish
vaccin
could
made
plant
immunogen
inject
gavag
earli
work
much
present
work
focuss
use
classic
transgenesi
nuclear
transform
express
transplastom
especi
transform
chloroplast
express
champion
earli
year
inde
recent
review
tout
technolog
use
term
combat
bioterror
given
high
yield
obtain
streatfield
singh
et
al
singh
et
al
recent
review
protocol
transform
express
oral
administr
group
henri
daniel
particular
pioneer
much
regard
daniel
dhingra
daniel
earli
demonstr
group
potenti
chloroplast
express
product
tobacco
viabl
e
coli
cholera
vibrio
antigen
daniel
et
al
time
made
point
repeat
frequent
sinc
even
recombin
protein
express
chloroplast
often
seem
affect
plant
phenotyp
much
express
express
clostridium
tetanii
toxin
fragment
c
follow
tregon
et
al
demonstr
product
efficaci
bacillu
anthraci
anthrax
protect
antigen
pa
watson
et
al
aziz
et
al
koya
et
al
unsurprisingli
antigen
express
well
chloroplast
given
origin
similar
mechan
fold
lack
downstream
process
glycosyl
howev
possibl
first
anim
vaccin
protect
peptid
virul
canin
parvoviru
cpv
express
tobacco
chloroplast
translat
fusion
cholera
toxin
b
subunit
ctb
molina
et
al
could
elicit
neutralis
antibodi
mice
via
oral
rout
administr
molina
et
al
interest
sever
acut
respiratori
syndrom
coronaviru
spike
accumul
well
transform
chloroplast
li
et
al
anoth
recent
develop
demonstr
product
tobacco
chloroplast
effect
immunogen
laca
lectin
fragment
eukaryot
protist
pathogen
entamoeba
histolytica
caus
death
annual
subcutan
immunis
mice
produc
high
igg
titr
word
averag
yield
mg
leca
per
plant
produc
million
dose
vaccin
antigen
per
acr
transgen
plant
chebolu
daniel
recent
success
includ
highest
express
level
yet
achiev
gkg
protein
transplastom
tobacco
assembl
correctli
elicit
neutralis
antibodi
millan
et
al
despit
anoth
claim
express
well
chloroplast
fuse
chloroplast
protein
fragment
lenzi
et
al
protein
also
success
produc
rel
high
level
transplastom
tobacco
mgkg
assembl
vlp
similar
produc
anim
cell
make
first
hiv
antigen
produc
reason
quantiti
plant
scotti
et
al
also
possibl
glycosyl
barrier
may
breach
soon
well
novel
pathway
identifi
could
allow
chloroplast
kind
protein
matur
occur
er
golgi
compart
fay
daniel
howev
topic
cover
detail
elsewher
volum
discuss
gomord
et
al
tissu
cultur
system
product
vaccin
protein
alway
minor
part
total
effort
probabl
greater
level
technic
expertis
note
elsewher
fischer
et
al
rybicki
cell
cultur
offer
great
deal
advantag
term
cost
convent
bacteri
eukaryot
cell
cultur
system
requir
steril
contain
yield
gener
high
number
microalga
system
eg
chlorella
particularli
chlamydomona
spp
investig
see
fuhrmann
siripornadulsil
et
al
surzycki
et
al
howev
vaccin
promin
among
product
two
exampl
human
iga
antibodi
produc
transgen
chlamydomona
reinhardtii
mayfield
franklin
fusion
fmdv
gene
cholera
toxin
b
subunit
ctb
produc
chloroplast
organ
sun
et
al
without
evid
efficaci
howev
terrestri
cultur
also
investig
potenti
product
system
larg
percept
high
level
contain
possibl
produc
protein
bioreactor
good
manufactur
practic
gmp
condit
would
accept
regul
success
product
antibodi
antibodi
fragment
tobacco
cell
report
howev
pursu
group
transgen
somat
embryo
transgen
siberian
ginseng
use
product
system
e
coli
kang
et
al
seem
commercialis
interest
variant
cell
cultur
techniqu
demonstr
clonal
root
cultur
establish
agrobacterium
rhizogen
transform
n
benthamiana
could
express
foreign
protein
elev
level
absenc
select
year
skarjinskaia
et
al
potenti
success
rout
product
illustr
two
exampl
one
therapeut
protein
present
human
trial
worldwid
recombin
human
glucocerebrosidas
rgcd
produc
via
contain
dispos
bioreactor
system
carrot
tobacco
cell
shaaltiel
et
al
baum
press
licenc
product
purifi
inject
newcastl
diseas
viru
vaccin
chicken
produc
tobacco
cell
line
dow
agrosci
intend
sale
dow
agrosci
plant
cell
cultur
first
sight
much
less
technic
demand
cell
cultur
chines
hamster
ovari
cho
cell
use
routin
product
mani
human
therapeut
one
obviou
advantag
shown
product
suscept
kind
contamin
experienc
convent
system
june
press
releas
genzym
web
site
http
wwwgenzymecomcorpmediagenz
mention
interfer
cho
cell
product
commerci
gaucher
diseas
therapeut
infect
caliciviru
vesiviru
like
introduc
nutrient
use
manufactur
process
later
report
bethencourt
state
us
food
drug
administr
fda
contact
rival
manufactur
shire
basingstok
uk
carmiel
protalix
enzym
replac
therapi
gaucher
diseas
clinic
trial
file
treatment
protocol
would
allow
physician
use
drug
ahead
approv
viral
vector
use
time
express
foreign
protein
chimaer
coat
protein
plant
review
see
gleba
et
al
steinmetz
et
al
yusibov
et
al
howev
util
varieti
applic
expand
greatli
sinc
earli
use
rna
infect
plant
recombin
tobacco
mosaic
viru
tmv
yusibov
et
al
inde
one
first
vaccin
describ
recombin
tmv
malari
epitop
expos
virion
surfac
turpen
et
al
biosourc
technolog
later
becam
larg
scale
biolog
corp
vacavil
ca
usa
recombin
tmv
technolog
one
main
product
success
use
express
flagship
lymphoma
fv
epitop
vaccin
clinic
trial
signific
proof
principl
anim
model
success
use
rtmv
express
epitop
deriv
cottontail
rabbit
papillomaviru
crpv
rabbit
oral
papillomaviru
ropv
minor
capsid
protein
protect
inject
vaccin
palmer
et
al
group
also
show
crpv
major
capsid
protein
produc
either
via
transgenesi
via
rtmv
express
protect
rabbit
crpv
challeng
kohl
et
al
signific
find
anim
vaccin
demonstr
protect
lethal
fmdv
infect
mice
immunis
inject
foliar
extract
n
benthamiana
infect
rtmv
express
whole
fmdv
wigdorovitz
et
al
passiv
immunis
via
matern
antibodi
mous
pup
born
dam
immunis
purifi
fragment
protein
bovin
rotaviru
brv
produc
similarli
n
benthamiana
perez
filgueira
et
al
group
abl
improv
previous
poor
express
level
capsid
protein
transgen
n
tabacum
varsani
et
al
n
benthamiana
use
tmv
varsani
et
al
howev
express
level
still
well
achiev
later
possibl
use
express
andor
present
also
describ
recent
review
mccormick
palmer
plant
virus
success
use
either
peptid
display
express
whole
antigen
includ
potexvirus
potato
viru
x
pvx
bamboo
mosaic
viru
bamv
papaya
mosaic
viru
papmv
cowpea
mosaic
comoviru
cpmv
review
brennan
et
al
canizar
et
al
bean
yellow
dwarf
mastreviru
beydv
relat
alfalfa
mosaic
almv
cucumb
mosaic
virus
cmv
tomato
bushi
stunt
tombusviru
among
other
import
proof
concept
use
vehicl
includ
use
chimaer
cpmv
particl
display
peptid
deriv
outer
membran
protein
f
pseudomona
aeruginosa
protect
mice
model
human
chronic
pulmonari
infect
brennan
et
al
cpmv
carri
peptid
deriv
capsid
protein
cpv
protect
lethal
challeng
langeveld
et
al
express
human
papillomaviru
type
oncoprotein
n
benthamiana
use
crude
foliar
extract
vaccin
protect
mice
tumour
cell
challeng
franconi
et
al
use
chimaer
bamv
virion
display
partial
sequenc
fmdv
induc
humor
immun
respons
full
protect
fmdv
pig
yang
et
al
proof
papmv
particl
possess
intrins
properti
enhanc
respons
display
peptid
lacass
et
al
relat
find
pvx
engin
display
epitop
influenza
viru
nucleoprotein
np
activ
specif
cell
mice
lico
et
al
geminivirus
particular
subject
interest
mani
year
suppos
potenti
express
vector
shown
maiz
streak
mastreviru
msv
vector
could
express
significantli
elev
level
number
test
protein
maiz
cell
year
absenc
select
viabl
infecti
vector
palmer
et
al
palmer
rybicki
also
sever
review
geminivirus
express
vector
eg
palmer
rybicki
mor
et
al
vaccin
applic
describ
use
system
express
staphlococcu
endotoxin
b
seb
gene
increas
express
tobacco
cell
bombard
replic
vector
note
compar
control
hefferon
fan
filament
plant
virus
probabl
better
express
whole
particl
easili
accommod
larger
genom
unlik
isometr
major
problem
autonom
replic
plant
viru
vector
construct
spread
via
natur
mean
plant
loss
transgen
problem
whether
vector
deliv
via
inocul
ssrna
cdna
clone
capabl
gener
infecti
transcript
increas
replic
fit
delet
recombin
exampl
work
demonstr
crpv
protein
gene
express
n
benthamiana
via
rtmv
progress
lost
infect
plant
develop
lead
lower
yield
protein
obtain
transgen
tobacco
kohl
et
al
eleg
mean
get
around
problem
complet
redesign
plant
virus
involv
use
agrobacterium
tumefacien
system
deliveri
viral
genom
describ
follow
paragraph
agrobacterium
transient
express
exploit
fact
infiltr
intercellular
space
plant
leav
suspens
via
syring
result
mobilis
nuclei
larg
proport
cell
expos
subsequ
express
transgen
integr
episom
dna
review
fischer
et
al
techniqu
essenti
becom
gold
standard
determin
whether
given
gene
express
plant
cell
compart
protein
accumul
best
given
wide
varieti
vector
avail
intracellular
target
express
protein
optimis
express
transgen
becam
simpl
mani
construct
could
test
parallel
syring
infiltr
use
differ
version
basic
gene
differ
promot
differ
leader
organel
target
sequenc
one
first
applic
technolog
proof
transient
express
hbsag
gfp
hbsag
fusion
form
particl
vlp
similar
vaccin
hbsag
system
could
use
conform
screen
vaccin
protein
huang
mason
exampl
laboratori
gkg
express
protein
n
benthamiana
demonstr
protein
accumul
better
export
chloroplast
cytoplasm
assembl
vlp
elicit
neutralis
antibodi
mice
inject
without
adjuv
maclean
et
al
sever
group
success
express
hiv
antigen
peptid
chimaer
protein
yusibov
et
al
durrani
et
al
matoba
et
al
whole
virion
capsid
protein
zhang
et
al
obregon
et
al
lindh
et
al
none
antigen
particularli
relev
wider
search
hiv
vaccin
compar
hiv
env
gag
protein
exampl
baker
et
al
success
express
whole
low
level
howev
fusion
protein
could
express
mgkg
localis
chloroplast
success
booster
vaccin
humor
respons
mice
prime
gag
dna
vaccin
meyer
et
al
anoth
impress
recent
investig
aoust
et
al
aoust
et
al
report
similar
investig
potenti
plant
agroinfiltr
produc
influenza
vaccin
express
haemagglutinin
ha
anew
virus
agroinfiltr
n
benthamiana
show
yield
mgkg
assembl
correctli
trimer
moreov
bud
plasma
membran
apoplast
indent
vlp
larg
devoid
host
protein
purifi
vlp
highli
immunogen
two
dose
confer
complet
protect
lethal
challeng
heterolog
viru
one
signific
develop
field
recent
time
coupl
agroinfiltr
deliveri
cdna
encod
deconstruct
technolog
term
magnifect
gleba
et
al
becam
centrepiec
product
technolog
new
icon
genet
hall
germani
system
soon
use
landmark
vaccin
model
exercis
produc
recombin
yersinia
pesti
antigen
v
fusion
protein
purifi
antigen
inject
guinea
pig
protect
aerosol
challeng
virul
pesti
santi
et
al
first
realli
accept
product
level
hbsag
plant
system
also
achiev
use
viral
vector
mgkg
leaf
fresh
weight
product
dimer
assembl
vlp
huang
et
al
welcom
develop
report
recent
icon
genet
rescu
concept
personalis
lymphoma
vaccin
pioneer
defunct
lsbc
corp
use
vector
produc
lifelong
suppli
vaccin
littl
kg
n
benthamiana
rybicki
anoth
landmark
recent
report
popular
media
human
norwalk
noroviru
capsid
vaccin
could
easili
quickli
produc
icon
technolog
dylewski
rybicki
novel
version
launch
vector
musiychuk
et
al
also
use
produc
among
antigen
hpv
protein
influenza
viru
haemagglutinin
neuraminidas
domain
fuse
thermost
lichenas
lickm
fusion
appar
abl
activ
innat
adapt
immun
respons
vaccin
protect
tumour
mous
model
vaccin
viral
challeng
ferret
massa
et
al
mett
et
al
group
recent
use
vector
fusion
system
produc
fraction
v
antigen
pesti
demonstr
protect
cynomolgu
macaqu
aerosolis
bacteria
chichest
et
al
classic
launch
vector
host
rang
problem
amplifi
express
limit
mainli
n
benthamiana
address
icon
genet
fraunhof
usa
differ
plant
virus
brought
play
thu
icon
improv
tmv
turnip
potyviru
pvx
vector
rybicki
fraunhof
usa
investig
launch
vector
compris
cucumb
mosaic
alfalfa
mosaic
construct
pisum
sativum
varieti
green
et
al
new
vector
system
note
amplifi
protein
express
plant
includ
deriv
plant
dna
geminivirus
well
cpmv
improv
geminiviru
system
describ
earlier
vector
reprepa
compon
deliv
via
agroinfiltr
silenc
suppressor
protein
use
produc
hepat
b
core
antigen
hbc
norwalk
viru
capsid
protein
nvcp
high
level
replicon
vector
reprepa
cassett
without
work
well
huang
et
al
group
also
use
singl
plasmid
replicon
system
significantli
boost
express
hiv
vaccin
protein
n
benthamiana
compar
nonrepl
control
regnard
et
al
novel
technolog
previous
shown
effect
induc
express
protein
activ
technolog
inpact
farmacul
bioindustri
vic
australia
induc
system
allow
amplifi
transgen
express
even
highli
toxic
molecul
farmacul
rybicki
prove
equal
use
transient
express
set
technolog
deriv
extrem
potent
translat
modifi
region
utr
cpmv
allow
simultan
express
multipl
polypeptid
singl
plasmid
within
day
sainsburi
et
al
mani
discov
year
process
take
gene
encod
candid
vaccin
protein
express
plant
level
accept
econom
product
eg
mgkg
antibodi
far
trivial
process
inde
mani
case
yield
low
especi
transgen
plant
proof
efficaci
suffer
result
concern
oral
vaccin
scheme
experi
shown
order
magnitud
protein
requir
via
oral
intak
parenter
level
immun
respons
protein
even
use
potent
adjuv
landmark
hbsag
human
clinic
trial
thanavala
et
al
case
point
parenter
vaccin
requir
hbsag
oral
boost
three
dose
potato
contain
hbsag
dose
around
mg
partial
effect
worth
note
much
higher
level
hbsag
express
sinc
obtain
huang
et
al
may
yet
make
dream
oral
hbv
vaccin
realiti
direct
comparison
oral
vs
parenter
dose
hpv
vaccin
determin
insect
hpv
vlp
adjuv
requir
oral
immunis
mice
respons
elicit
inject
rose
et
al
gerber
et
al
other
shown
oral
administr
crude
extract
insect
cell
could
induc
neutralis
antibodi
cytotox
indic
similar
plant
prepar
might
sinc
yield
gkg
obtain
exampl
attempt
optimis
express
human
pathogen
major
capsid
protein
previous
manag
produc
level
via
tmv
express
varsani
et
al
group
first
investig
effect
chang
type
tobacco
use
transgen
express
use
agroinfiltr
effect
use
gene
three
differ
codon
optimis
target
protein
cytoplasm
er
chloroplast
maclean
et
al
simpli
chang
host
n
tabacum
cv
xanthi
allow
increas
express
nativ
viral
gene
varsani
j
maclean
ep
rybicki
unpublish
mgkg
via
agroinfiltr
work
reiter
surpris
earlier
find
human
optimis
gene
work
best
biemelt
et
al
plant
version
least
well
compar
nativ
gene
sequenc
despit
use
complet
differ
optimis
group
remov
amino
acid
dramat
improv
express
yeast
insect
neg
effect
agroinfiltr
plant
also
show
chloroplast
export
allow
significantli
greater
protein
accumul
cytoplasm
subsequ
gener
transgen
tobacco
relev
construct
reiter
cytoplasm
vs
chloroplast
accumul
differ
increas
factor
previou
best
transgen
yield
around
mgkg
howev
achiev
gener
plant
regener
transform
callu
express
subsequ
gener
either
much
lower
complet
absent
j
maclean
koekemo
ep
rybicki
unpublish
point
anoth
problem
attempt
maximis
constitut
nuclear
gene
transgen
express
fact
gene
silenc
may
occur
thu
protein
achiev
plant
level
could
allow
oral
vaccin
made
appear
agroinfiltr
plant
transplastom
plant
rather
stabli
transform
convent
transgen
optimis
relev
hiv
antigen
express
also
instruct
lesson
convent
develop
hiv
vaccin
utilis
approach
focuss
whole
gag
env
protein
particular
seem
one
success
express
whole
hiv
env
protein
even
major
protein
plant
reason
express
siv
report
maiz
seed
horn
et
al
specul
may
misdirect
new
protein
calreticulin
pathway
howev
hard
evid
j
per
commun
also
appear
difficult
express
portion
gag
plant
via
stabl
transient
nuclear
transform
reason
yield
meyer
et
al
tat
protein
produc
quit
high
yield
spinach
tomato
karasev
et
al
ramirez
et
al
capsid
protein
tobacco
arabidopsi
zhang
et
al
obregon
et
al
lindh
et
al
protein
seriou
vaccin
candid
global
hiv
vaccin
hunt
hearten
therefor
scotti
et
al
scotti
et
al
recent
report
possibl
produc
whole
protein
level
mgkg
transplastom
tobacco
fact
protein
assembl
vlp
like
produc
anim
cell
system
increasingli
seen
potenti
hiv
vaccin
speth
et
al
chege
et
al
mean
viabl
stimul
hiv
vaccin
may
final
could
even
oral
administ
given
kind
yield
demonstr
may
possibl
extent
predict
way
increas
recombin
protein
express
plant
suspect
basi
experi
protein
hpv
hiv
protein
antibodi
fragment
influenza
viru
ha
protein
gene
orbivirus
document
experi
other
process
complet
empir
automat
assumpt
plant
codon
usag
optim
assumpt
base
experi
cell
cultur
system
one
univers
suitabl
host
product
system
although
use
agroinfiltr
deconstruct
plant
viral
vector
seem
way
becom
industri
standard
advis
explor
intracellular
organel
export
target
option
also
plastid
transform
plastid
target
protein
cytoplasm
synthesi
may
predict
happen
mrna
express
translat
organel
principl
illustr
simpl
exampl
taken
work
figur
effect
express
two
version
gag
construct
agroinfiltr
n
benthamiana
use
rang
vector
target
protein
cytoplasm
er
chloroplast
seen
truncat
gag
gene
encod
matrix
capsid
ca
protein
fusion
without
myristyl
signal
myrist
acid
addit
allow
associ
precursor
protein
presum
cell
membran
subsequ
bud
vlp
myristyl
version
bud
differ
total
accumul
either
version
insect
cell
halsey
et
al
case
nativ
accumul
significantli
better
chloroplast
cytoplasm
er
chang
singl
amino
acid
cancel
myristyl
significantli
reduc
accumul
especi
chloroplast
meyer
et
al
thu
express
protein
insect
anim
cell
differ
mention
previous
nuclear
express
whole
plant
low
inde
whatev
target
contrast
insect
cell
express
protein
hand
give
reason
yield
jaffray
et
al
halsey
et
al
determin
myristyl
may
also
signific
factor
take
account
consid
express
potenti
protein
public
profil
vaccin
much
reduc
sinc
heyday
grow
vaccin
time
feasibl
potenti
efficaci
vaccin
well
establish
may
time
come
last
mani
group
experi
express
antigen
human
pathogen
plant
peopl
work
anim
model
anim
pathogen
abl
demonstr
convinc
proof
efficaci
vaccin
gener
oral
inject
version
among
leader
work
sever
version
vaccin
produc
via
differ
group
instituto
de
virologia
bueno
air
see
review
du
santo
wigdorovitz
work
extens
fmdv
vaccin
shown
efficaci
case
du
santo
et
al
also
recent
abl
produc
partial
purifi
bovin
viral
diarrhoea
viru
glycoprotein
subunit
vaccin
transgen
alfalfa
inject
equival
amount
two
dose
antigen
protect
cattl
better
convent
vaccin
report
rybicki
quit
possibl
first
target
product
vaccin
diseas
anim
given
easier
rout
demonstr
efficaci
potenti
far
shorter
regulatori
path
demonstr
dow
ndv
vaccin
dow
agrosci
prospect
human
vaccin
clear
much
activ
produc
altern
establish
hbv
hpv
rotavirus
simpl
fact
either
alreadi
enorm
establish
convent
capac
product
gener
case
hbv
cheap
enough
includ
extend
programm
immunis
epi
univers
infant
vaccin
bundl
much
capit
involv
develop
product
plant
new
hpv
rotaviru
vaccin
big
pharma
interest
diversifi
mean
product
point
elsewher
even
reduct
cost
materi
product
plant
neglig
amount
would
lower
cost
biosimilar
gener
version
establish
vaccin
fraction
retail
price
cost
includ
downstream
process
remain
rybicki
thu
probabl
option
attempt
compet
establish
product
use
uniqu
advantag
huge
rang
scalabl
speed
leverag
nich
orphan
vaccin
emerg
diseas
vaccin
even
bioterror
threat
mean
product
simpli
slow
respond
worth
stress
point
made
charl
arntzen
report
elsewher
rybicki
plant
advantag
older
technolog
speed
new
product
platform
flexibl
term
sever
way
produc
antigen
regard
deconstruct
viral
vector
even
simpl
agroinfiltr
extrem
potent
tool
pilot
product
scale
product
scenario
inde
time
new
influenza
pandem
possibl
impress
demonstr
potenti
vaccin
fact
two
group
medicago
inc
canada
fraunhof
recent
manag
go
ha
sequenc
purif
gram
protein
less
month
via
transient
express
tobacco
rybicki
almost
certainli
fastest
product
ever
current
pandem
even
season
influenza
vaccin
repres
thorough
vindic
approach
influenza
pandem
respons
potenti
technolog
explor
elsewher
volum
aoust
et
al
subject
new
technolog
influenza
season
pandem
vaccin
particular
use
plant
well
comprehens
review
recent
chichest
et
al
suffic
say
ampl
evid
plant
may
viabl
vehicl
even
convent
vaccin
product
prevent
influenza
recent
demonstr
abil
vaxx
inc
quickli
produc
gram
quantiti
noroviru
subunit
vaccin
dylewski
also
promis
given
viru
subject
rapid
mutat
chang
recent
news
regulatori
front
favour
first
european
guidelin
grow
plant
produc
pharmaceut
genet
modifi
european
food
safeti
author
efsa
publish
august
gilbert
appar
consist
us
food
drug
administr
depart
agricultur
mean
much
northern
hemispher
match
guidelin
pmp
recent
review
human
trial
oral
vaccin
summaris
human
studi
oral
transgen
vaccin
enterotoxigen
e
coli
infect
noroviru
hbv
add
weight
grow
bodi
evid
oral
vaccin
virus
feasibl
effect
tacket
mani
proof
concept
sever
efficaci
oral
immunis
anim
recent
demonstr
high
yield
human
vaccin
candid
obtain
via
plastid
transform
transient
express
plant
make
dream
oral
vaccin
charl
arntzen
quot
rybicki
suddenli
almost
reachabl
exampl
may
true
much
antigen
need
via
oral
rout
requir
parenter
immun
respons
much
antigen
reliabl
provid
one
tobacco
plant
suitabl
cheapli
purifi
simpl
process
becom
emin
possibl
exploit
technolog
origin
goal
regulatori
front
fda
approv
inject
purifi
antibodi
fragment
use
individualis
vaccin
human
trial
lymphoma
therapi
mccormick
et
al
first
inject
human
vaccin
deriv
plant
mean
rout
immunis
open
well
fact
insist
among
mani
research
field
oral
administr
need
mucos
immun
may
need
rethink
assumpt
landmark
articl
follow
quot
may
give
paus
thought
base
observ
comparison
mucos
parenter
vaccin
convent
vaccin
suggest
develop
serum
immunolog
respons
effect
prevent
system
diseas
regardless
type
vaccin
rout
administr
howev
induct
antibodi
cellular
immun
mucos
site
emphasi
best
elicit
mucos
applic
antigen
kaul
ogra
thu
vaccin
may
overlap
far
formerli
thought
possibl
convent
vaccin
inject
biosimilar
even
biobett
defin
yuri
gleba
rybicki
could
compet
directli
produc
ferment
anim
cell
cultur
futur
vaccin
alway
seem
bright
also
disjunct
present
futur
hard
bridg
exampl
appear
obviou
subunit
vaccin
made
plant
none
even
anim
despit
proof
efficaci
year
also
much
made
appar
reluct
larg
pharmaceut
compani
becom
eg
bayer
dow
impact
profound
perhap
take
increment
success
therapeut
protalix
glucocerebrocidas
japanes
aist
group
canin
produc
strawberri
treatment
dog
periodont
diseas
rybicki
follow
vaccin
livestock
argentinean
bvdv
vaccin
human
therapeut
rabi
viru
antibodi
even
insulin
vaccin
like
icon
genet
nhl
product
final
tip
balanc
accept
vaccin
human
use
appar
accept
relev
fund
agenc
usa
vaccin
aim
potenti
bioterror
agent
anthrax
haemorrhag
fever
virus
could
easili
made
plant
may
valuabl
lever
regard
accept
happen
soon
obviou
first
militari
nich
market
orphan
diseas
vaccin
lassa
fever
south
american
haemorrhag
fever
virus
low
volum
market
rather
competitor
blockbust
vaccin
hpv
rotaviru
increas
accept
long
term
could
mean
shift
mainstream
high
volumelow
cost
gener
would
appear
ideal
suit
technolog
regulatori
landscap
also
less
intimidatori
often
recent
develop
european
union
prepar
pharm
drug
may
mean
chang
becom
even
less
gilbert
rybicki
hope
barrier
applic
promis
technolog
soon
orphan
vaccin
orphan
